IRIS
AMODIO, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.430
AS - Asia 1.370
EU - Europa 1.153
SA - Sud America 141
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 2
Totale 5.132
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.348
SG - Singapore 938
IT - Italia 566
CN - Cina 259
SE - Svezia 197
BR - Brasile 124
GB - Regno Unito 110
DE - Germania 106
CA - Canada 68
IN - India 42
FI - Finlandia 34
HK - Hong Kong 31
RO - Romania 26
BD - Bangladesh 19
NL - Olanda 16
EU - Europa 15
PL - Polonia 15
CZ - Repubblica Ceca 13
VN - Vietnam 12
FR - Francia 11
JP - Giappone 11
MX - Messico 11
EG - Egitto 10
ES - Italia 10
UA - Ucraina 10
IR - Iran 9
RU - Federazione Russa 9
TR - Turchia 8
IQ - Iraq 7
AT - Austria 6
ZA - Sudafrica 6
CH - Svizzera 5
GR - Grecia 5
PK - Pakistan 5
VE - Venezuela 5
YE - Yemen 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
LT - Lituania 4
SA - Arabia Saudita 4
EC - Ecuador 3
EE - Estonia 3
MY - Malesia 3
AU - Australia 2
DK - Danimarca 2
IL - Israele 2
JO - Giordania 2
PA - Panama 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BO - Bolivia 1
CO - Colombia 1
ET - Etiopia 1
GE - Georgia 1
IE - Irlanda 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.132
Salva come PNG Salva come JPEG
Città #
Singapore 431
Chandler 388
Santa Clara 233
Lawrence 189
Princeton 189
Milan 188
Catanzaro 134
Wilmington 106
Chicago 86
London 86
Munich 83
Beijing 72
Ashburn 67
Des Moines 57
Ottawa 47
Boardman 34
Hong Kong 31
Turku 30
Shanghai 24
Los Angeles 21
Redwood City 20
Brooklyn 16
Guangzhou 16
São Paulo 16
Council Bluffs 14
Horia 14
Pune 14
San Francisco 14
The Dalles 14
Warsaw 14
Norwalk 13
New York 12
Olomouc 12
Rome 11
Boston 10
Hanover 10
Naples 10
Phoenix 10
Redmond 10
Timisoara 10
Cosenza 9
San Jose 9
Bari 8
Columbus 8
Montreal 8
Stockholm 8
Ann Arbor 7
Charlotte 7
Jiaxing 7
Lamezia Terme 7
Mexico City 7
Ovada 7
San Nicola Manfredi 7
Settingiano 7
Shenzhen 7
Chennai 6
Dhaka 6
Hefei 6
Palermo 6
Parma 6
Reggio Calabria 6
West Jordan 6
Andover 5
Ankara 5
Atlanta 5
Augusta 5
Aversa 5
Manchester 5
Nanjing 5
Sanaa 5
Amsterdam 4
Caserta 4
Hanoi 4
Hebei 4
Helsinki 4
Ho Chi Minh City 4
Johannesburg 4
Novokuznetsk 4
Taranto 4
Toronto 4
Xi'an 4
Ahmedabad 3
Belo Horizonte 3
Cairo 3
Cetraro 3
Denver 3
Duhok 3
Fayetteville 3
Lahore 3
Masera 3
Napoli 3
Praia Grande 3
Raleigh 3
San Mateo 3
Seattle 3
Tokyo 3
Treviso 3
Vancouver 3
Vienna 3
Zhengzhou 3
Totale 3.052
Salva come PNG Salva come JPEG
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 85
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 66
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells 63
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells in vitro 60
LNA-Gapmer Antisense Oligonucleotides Targeting the Oncogenic Lncrna MALAT1 Trigger Anti-Multiple Myeloma Activity By Proteasome Blockade 56
Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells 55
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer 52
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells 52
Molecular and clinical types of plasma cell dyscrasias are associated with distinct expression patterns of long noncoding RNAs 51
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 51
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease 50
MIR-21 SUPPRESSION IMPAIRS TH17 RELATED BONE DISEASE IN MULTIPLE MYELOMA 49
MYC-MIR-22 REGULATORY LOOP MODULATES LENALIDOMIDE ACTIVITY IN MULTIPLE MYELOMA CELLS 49
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 49
Impact of natural dietary agents on multiple myeloma prevention and treatment: molecular insights and potential for clinical translation. 48
Turning Stem Cells Bad: Generation of Clinically Relevant Models of Human Acute Myeloid Leukemia through Gene Delivery- or Genome Editing-Based Approaches 47
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 47
TARGETING OF DEREGULATED LNCRNA NEAT1 AFFECTS MULTIPLE MYELOMA ACTIVITY 45
Early Hematopoietic Zinc Finger protein (EHZF), the human homologue to Evi3, is highly expressed in primitive human hematopoietic cells 45
ACTIVATION OF GPER SIGNALING AS A POTENTIAL THERAPEUTIC STRATEGY AGAINST WALDENSTROM MACROGLOBULINEMIA 45
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 45
Early hematopoietic zinc finger protein, a novel transcription co-factor with a potential role in haematopoietic homeostasis and leukaemogenesis 44
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 44
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 43
ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer 43
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 43
ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer. 42
P21-ACTIVATED KINASE 4 (PAK4) REGULATES MULTIPLE MYELOMA (MM) CELL GROWTH AND SURVIVAL BY MODULATION OF CRITICAL TRANSCRIPTIONAL PATHWAYS: THERAPEUTIC APPLICATION OF PAK4 ALLOSTERIC INHIBITORS 42
Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation 41
Anti-MALAT1 synthetic oligonucleotides target the proteasome and exert anti-multiple myeloma activity 41
Inhibitor of DNA binding 2 (ID2) regulates key transcriptional programs in multiple myeloma 41
Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction 40
Synthesis and preliminary evaluation of the anti-cancer activity on A549 lung cancer cells of a series of unsaturated disulfides. 39
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. 38
Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment 38
Radiation induced by-stander effect: possible RNA implication in DNA damage transmission? 38
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 38
Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma 37
Activation of the Non-Canonical Estrogen Receptor Gper As a Novel Therapeutic Strategy Against Waldenstrom Macroglobulinemia 37
Contribution of PKB/AKT signaling to thyroid cancer 37
Znf521 enhances mll‐af9‐dependent hematopoietic stem cell transformation in acute myeloid leukemias by altering the gene expression landscape† 37
In Vitro Silencing of lncRNAs Using LNA GapmeRs 37
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 37
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. 36
Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma 36
In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma 36
A 13 mer LNA miR-221 inhibitor restores drug sensitivity in melphalan-refractory multiple myeloma cells 36
CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network 36
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 35
Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation 35
Alternative non-homologous end joining DNA repair as therapeutic target in multiple myeloma 34
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells 34
From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario 33
In vitro expansion of tumour cells derived from blood and tumour tissue is useful to redefine personalized treatment in non-small cell lung cancer patients 33
Biological Insights into Myeloma and Other B Cell Malignancies 33
MiR-34a Replacement As a Novel Therapeutic Approach for Multiple Myeloma: Preclinical In Vitro and In Vivo Evidence 33
Early hematopoietic zinc finger protein prevents tumor cell recognition by natural killer cells 33
MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment 32
In vitro and vivo activity against multiple myeloma cells of a novel locked nucleic acid (LNA)-miR-221 inhibitor 32
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 32
Early hematopoietic zinc finger protein - zinc finger protein 521 (EHZF/ZNF521): a candidate regulator of diverse immature cells 32
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 30
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 30
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth 30
Activating E17K mutation in the gene encoding the protein kinase B/AKT in squamous cell carcinoma of the lung 30
The non-coding RNA landscape of plasma cell dyscrasias 30
Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma 29
Early Hematopoietic Zinc Finger (EHZF/ZNF521) prevents tumor cell recognition by Natural Killer Cells 29
The chromogranin A1-373 fragment reveals how a single change in the protein sequence exerts strong cardioregulatory effects by engaging neuropilin-1 29
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia 28
Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients 28
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 27
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma 27
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells. 27
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 27
Non-coding RNA: A novel opportunity for the personalized treatment of multiple myeloma 26
Arginine Methylation Mediated By PRMT5 Has Significant Biological and Clinical Impact in Multiple Myeloma 26
Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart 26
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma. 26
Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injury 26
Functional Analysis of microRNA in Multiple Myeloma 25
miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies 25
Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors 25
Selective Activation of the Non-Classical Estrogen Receptor Gper Elicits Potent Anti-Tumor Activity in Multiple Myeloma 24
Early Hematopoietic Zinc Finger protein (EHZF), a novel co-transcription factor: functional properties, expression in myelogenous leukaemias and interactions with histone deacetylases 24
Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment. 24
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 24
Contribution of PKB/AKT signaling to thyroid cancer 23
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma 23
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment. 23
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 23
Selective G-Protein Estrogen Receptor (GPER) Activation Triggers Anti-Multiple Myeloma Activity and Synergizes with MiR-29b-Inducing Drugs 23
Current status and future perspectives on therapeutic potential of apigenin: Focus on metabolic-syndrome-dependent organ dysfunction 23
Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma 22
MiR-29b Exerts Anti-Multiple Myeloma Activity by Targeting Key Oncogenic Pathways and Modulating DNA Methylation Profile 22
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 22
MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches 22
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 21
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor 21
Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma 21
Totale 3.589
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.235
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021318 0 3 14 14 34 21 20 14 54 45 72 27
2021/2022569 23 2 5 154 38 13 24 113 54 61 71 11
2022/20231.183 386 64 71 68 100 93 5 87 163 51 70 25
2023/2024515 113 73 34 42 28 129 13 8 2 14 19 40
2024/20252.129 321 95 65 58 151 302 44 51 266 130 214 432
2025/2026386 264 122 0 0 0 0 0 0 0 0 0 0
Totale 5.362